ACRO Leadership

The Association of Clinical Research Organizations (ACRO) is lead by a distinguished team of business, drug development and technology experts that comprise ACRO’s Board of Directors. Our Board of Directors is dedicated to advocating on behalf of safe, ethical clinical trials that protect patients and ensure high-quality results.

All Regular ACRO members maintain a seat on our Board of Directors. In addition, our Board’s Executive Committee is made up of the current ACRO Chair, Vice-Chair, and the immediate Past-Chair.

Board of Directors

Steve Cutler

ACRO Chair & CEO, ICON

Jackie Kent

ACRO Vice-Chair and EVP & Head of Product, Medidata Solutions

Alistair Macdonald

Previous ACRO Chair & CEO, Syneos Health

Cynthia Verst

President Clinical Operations, IQVIA

Suresh Katta

Chief Executive Officer, Saama Technologies

David Coman

Chief Executive Officer, Science37

Henry Mcnamara

SVP & GM, Oracle Health Sciences

Roger Smith

CEO, Signant Health

Paul Kirchgraber

CEO, Covance Drug Development

Peyton Howell

Chief Commercial and Strategy Officer, Parexel

David Johnston

Executive Vice President of Global Clinical Development, PPD

Euan Menzies

CEO, Bioclinica

Joe Eazor

President & CEO, ERT

Henry Levy

General Manager, Veeva

Become and ACRO Member and add your voice.

ACRO Staff

Working together with ACRO’s member companies, our staff is committed to leveraging their collective experience in public policy, clinical research, communications and government relations to advance ACRO’s mission on behalf of our industry.

Doug Peddicord

Executive Director

Karen Noonan

Senior Vice President, Global Regulatory Policy

Anina Adelfio

Vice President, Industry Relations

Sophia McLeod

Director of Government Relations

Elyssa Clauson

Associate, Membership and Communications